The Best of Both: Scoops and Analysis
With
TheStreet.com's
new design, it's more apparent that
Deion Sanders
has nothing on us. The breadth and tightness of our coverage is Primetime.
With everything that's happening during market hours, readers can't read everything, so here's a look at a collection of our best.
Scoops
We got more than a truckload of
Raisin Bran
.
George Mannes and Suzanne Galante, our two horticulturalists covering tulips, broke the news that
Yahoo!
(YHOO)
was in talks to acquire
GeoCities
(GCTY)
.
Yahoo!, GeoCities Talking Merger
http://www.thestreet.com/tech/internet/692140.html
Alex Berenson, perhaps the only media reporter in the country who doesn't own a TV, came up with a scoop of his own this week:
Disney, Chancellor Media Discuss a Linkup
http://www.thestreet.com/stocks/media/688579.html
Jesse Eisinger,
TSC's
drug reporter, came up with the first look at the data on the launch of
Monsanto's
(MTC) - Get Report
arthritis drug:
A Celebrated Start For Monsanto's Celebrex
http://www.thestreet.com/stocks/biotech/687587.html
.
Analysis
When
TSC
reporters aren't breaking news, they're providing thoughtful analysis.
Is being first best or being best best? That's the question that George Mannes asked in his piece on the advantage of being first on the Internet:
First-Mover Advantage: What's It Really Worth?
http://www.thestreet.com/tech/internet/682198.html
.
Retail reporter Suzanne Kapner wondered if the strong
North Face
(TNFI)
brand is heading south:
Retailer Risks Cutting Off Nose to Spite Its North Face
http://www.thestreet.com/stocks/retail/688970.html
.
Marcy Burstiner showed that despite protesters,
Intel
(INTC) - Get Report
will benefit from selling trackable chips:
Despite Boycott, Trackable Chips Are Good for Intel
http://www.thestreet.com/tech/semis/686295
.
Eric Moskowitz took a look at the new way companies are trying to sell their stock:
The Evolving Art of Interpreting Insider Buying
http://www.thestreet.com/stocks/retail/688146.html
A big biotech deal warranted some thoughts on the deal's wider implications:
Agouron Deal Signals Big Pharma Is Warming to Biotech
http://www.thestreet.com/stocks/biotech/689484
.
The air is so thin in Wyoming, it's a wonder that economics correspondent James Padinha can think at all. But he proved thoughtful as he weighed in on Alan Greenspan's comments on Net Lotto:
On Internet "Investing"
http://www.thestreet.com/comment/economics/694561.html
.
Nick Watson's piece on a weakening Rupert Murdoch should keep Fleet Streeters warm on winter nights:
Murdoch's U.K. Cable Stranglehold Loosens"
http://www.thestreet.com/int/euromarkets/694961.html
.
Commentator Lewis Perdue took a shot at gun sales on the Internet with this piece:
Excite and eBay: Flirting With Disaster?
http://www.thestreet.com/comment/cfeatures/681789.html
